Condition: Liver Inflammation · Fatty Liver Disease · Sponsor: Wuxi Hisky Medical Technology Co Ltd
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
This description comes directly from the study's public registry record.
Lai Wei · +86 13601281862 · weilai@pkuph.edu.cn
Always discuss trial participation with your own doctor first.
| Beijing Tsinghua Changgung Hospital (BTCH) affiliated to Tsinghua University | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06802731